TNF/TNFR family members in costimulation of T cell responses.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Annual Review of Immunology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1146/ANNUREV.IMMUNOL.23.021704.115839PMID 15771565
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• T cell memory.

  2006cited by this paper
• Cutting Edge: The Natural Ligand for Glucocorticoid-Induced TNF Receptor-Related Protein Abrogates Regulatory T Cell Suppression 1

  2004cited by this paper
• Essential Role of OX40L on B Cells in Persistent Alloantibody Production Following Repeated Alloimmunizations

  2004cited by this paper
• The costimulation-regulated duration of PKB activation controls T cell longevity

  2004cited by this paper
• Use of CD134 As a Primary Receptor by the Feline Immunodeficiency Virus

  2004cited by this paper
• 4‐1BB‐dependent inhibition of immunosuppression by activated CD4+CD25+ T cells

  2004cited by this paper
• Costimulatory ligand 4-1BBL (CD137L) as an efficient adjuvant for human antiviral cytotoxic T cell responses.

  2004cited by this paper
• Regulation of Dendritic Cell Function by NK Cells: Mechanisms Underlying the Synergism in the Combination Therapy of IL-12 and 4-1BB Activation1

  2004cited by this paper
• Stimulation by Soluble CD70 Promotes Strong Primary and Secondary CD8+ Cytotoxic T Cell Responses In Vivo 1

  2004cited by this paper
• Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy.

  2004cited by this paper
• Expression of Costimulatory Molecules (4-1BBL and Fas) and Major Histocompatibility Class I Chain-Related A (MICA) in Aortic Tissue with Takayasu’s Arteritis

  2004cited by this paper
• Ligation of CD137 receptor prevents and reverses established anergy of CD8+ cytolytic T lymphocytes in vivo.

  2004cited by this paper
• Expression and function of 4‐1BB during CD4 versus CD8 T cell responses in vivo

  2004cited by this paper
• Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40

  2004cited by this paper
• TNF Receptor-Associated Factor 5 Limits the Induction of Th2 Immune Responses1

  2004cited by this paper
• Plasmacytoid Dendritic Cells Regulate Th Cell Responses through OX40 Ligand and Type I IFNs1

  2004cited by this paper
• Detection and characterization of OX40 ligand expression in human airway smooth muscle cells: a possible role in asthma?

  2004cited by this paper
• Distinct Roles for the OX40-OX40 Ligand Interaction in Regulatory and Nonregulatory T Cells1

  2004cited by this paper
• Critical Role of OX40 in CD28 and CD154-Independent Rejection1

  2004cited by this paper
• Engagement of Glucocorticoid-Induced TNFR Family-Related Receptor on Effector T Cells by its Ligand Mediates Resistance to Suppression by CD4+CD25+ T Cells

  2004cited by this paper
• Extremely Rapid and Intense Induction of Apoptosis in Human Eosinophils by Anti-CD30 Antibody Treatment In Vitro

  2004cited by this paper
• Tumor Rejection Induced by CD70-mediated Quantitative and Qualitative Effects on Effector CD8+ T Cell Formation

  2004cited by this paper
• Role of T cell costimulation in anti-viral immunity.

  2004cited by this paper
• Frontline: GITR, a member of the TNF receptor superfamily, is costimulatory to mouse T lymphocyte subpopulations

  2004cited by this paper
• Expression of CD30 and Ox40 on T lymphocyte subsets is controlled by distinct regulatory mechanisms

  2004cited by this paper
• This information is current as Responses Facilitate Robust CD 8 and CD 4 Recall 4-1 BB and OX 40 Act Independently to and

  2004cited by this paper
• A Signal through OX40 (CD134) Allows Anergic, Autoreactive T Cells to Acquire Effector Cell Functions1

  2004cited by this paper
• A Switch in Costimulation from CD28 to 4-1BB during Primary versus Secondary CD8 T Cell Response to Influenza In Vivo1

  2004cited by this paper
• Retroviral transduction of acute myeloid leukaemia‐derived dendritic cells with OX40 ligand augments their antigen presenting activity

  2004cited by this paper
• CD27 Is Acquired by Primed B Cells at the Centroblast Stage and Promotes Germinal Center Formation1

  2004cited by this paper
• Costimulation of CD8 T Cell Responses by OX401

  2004cited by this paper
• Priming of naive T cells inside tumors leads to eradication of established tumors

  2004cited by this paper
• Costimulation via Glucocorticoid-Induced TNF Receptor in Both Conventional and CD25+ Regulatory CD4+ T Cells1

  2004cited by this paper
• Extremely rapid and intense induction of apoptosis in human eosinophils by anti-CD30 antibody treatment in vitro.

  2004cited by this paper
• Cutting Edge: Ligation of the Glucocorticoid-Induced TNF Receptor Enhances Autoreactive CD4+ T Cell Activation and Experimental Autoimmune Encephalomyelitis1

  2004cited by this paper
• Siva-1 and an Alternative Splice Form Lacking the Death Domain, Siva-2, Similarly Induce Apoptosis in T Lymphocytes via a Caspase-Dependent Mitochondrial Pathway1

  2004cited by this paper
• Immunotherapy with OX40L‐Fc or anti‐CTLA‐4 enhances local tissue responses and killing of Leishmania donovani

  2004cited by this paper
• CD40/CD154 interactions at the interface of tolerance and immunity.

  2004cited by this paper
• CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis.

  2003cited by this paper
• A translational bridge to cancer immunotherapy

  2003cited by this paper
• Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

  2003cited by this paper
• graft rejection in allogeneic bone marrow transplant recipients Ligation of OX 40 ( CD 134 ) regulates graft-versus-host disease ( GVHD )

  2003cited by this paper
• IL-13 effector functions.

  2003cited by this paper
• Blocking 4-1BB/4-1BB Ligand Interactions Prevents Herpetic Stromal Keratitis1

  2003cited by this paper
• OX40-Mediated Memory T Cell Generation Is TNF Receptor-Associated Factor 2 Dependent 1

  2003cited by this paper
• Expression of the Murine CD27 Ligand CD70 In Vitro and In Vivo4

  2003cited by this paper
• T cell memory.

  2003cited by this paper
• Ligation of CD27 on B Cells In Vivo during Primary Immunization Enhances Commitment to Memory B Cell Responses 1

  2003cited by this paper
• Control of immune homeostasis by naturally arising regulatory CD4+ T cells.

  2003cited by this paper
• CD27 Promotes Survival of Activated T Cells and Complements CD28 in Generation and Establishment of the Effector T Cell Pool

  2003cited by this paper
• OX40 (CD134) Controls Memory T Helper 2 Cells that Drive Lung Inflammation

  2003cited by this paper
• The signaling adaptors and pathways activated by TNF superfamily.

  2003cited by this paper
• LIGHT-HVEM signaling and the regulation of T cell-mediated immunity.

  2003cited by this paper
• Enhanced Effector and Memory CTL Responses Generated by Incorporation of Receptor Activator of NF-κB (RANK)/RANK Ligand Costimulatory Molecules into Dendritic Cell Immunogens Expressing a Human Tumor-Specific Antigen 12

  2003cited by this paper
• Role of CD4 T Cell Help and Costimulation in CD8 T Cell Responses During Listeria monocytogenes Infection 1

  2003cited by this paper
• LIGHT, a new TNF superfamily member, is essential for memory T helper cell‐mediated activation of dendritic cells

  2003cited by this paper
• CD4(+)CD3(-) accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells.

  2003cited by this paper
• LIGHT (a Cellular Ligand for Herpes Virus Entry Mediator and Lymphotoxin Receptor)-Mediated Thymocyte Deletion Is Dependent on the Interaction Between TCR and MHC/Self-Peptide1

  2003cited by this paper
• Critical roles of CD30/CD30L interactions in murine autoimmune diabetes

  2003cited by this paper
• Expression of CD137 and its ligand in human neurons, astrocytes, and microglia: Modulation by FGF‐2

  2003cited by this paper
• Costimulation of human CD28– T cells by 4‐1BB ligand

  2003cited by this paper
• Lymphotoxin/LIGHT, lymphoid microenvironments and autoimmune disease

  2003cited by this paper
• Regulation of Murine Inflammatory Bowel Disease by CD25+ and CD25− CD4+ Glucocorticoid-Induced TNF Receptor Family-Related Gene+ Regulatory T Cells1

  2003cited by this paper
• Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions

  2003cited by this paper
• Critical role for OX40 ligand in the development of pathogenic Th2 cells in a murine model of asthma

  2003cited by this paper
• OX40 Ligand-Transduced Tumor Cell Vaccine Synergizes with GM-CSF and Requires CD40-Apc Signaling to Boost the Host T Cell Antitumor Response1

  2003cited by this paper
• OX40/OX40L interaction induces the expression of CXCR5 and contributes to chronic colitis induced by dextran sulfate sodium in mice

  2003cited by this paper
• Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells

  2003cited by this paper
• Identification of a ligand for glucocorticoid-induced tumor necrosis factor receptor constitutively expressed in dendritic cells.

  2003cited by this paper
• Frequencies of Circulating Cytolytic, CD45RA+CD27−, CD8+ T Lymphocytes Depend on Infection with CMV1

  2003cited by this paper
• Therapeutic effect of anti-OX40L and anti-TNF-alpha MAbs in a murine model of chronic colitis.

  2003cited by this paper
• Death Decoy Receptor TR6/DcR3 Inhibits T Cell Chemotaxis In Vitro and In Vivo1

  2003cited by this paper
• Hodgkin’s Lymphoma and CD30 Signal Transduction

  2003cited by this paper
• Expression and a role of CD30 in regulation of T-cell activity

  2003cited by this paper
• Lineage relationship and protective immunity of memory CD8 T cell subsets

  2003cited by this paper
• A Critical Role for OX40 in T Cell–mediated Immunopathology during Lung Viral Infection

  2003cited by this paper
• CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice.

  2003cited by this paper
• Cloning and characterization of GITR ligand

  2003cited by this paper
• Paradoxical Dampening of Anti-Islet Self-Reactivity but Promotion of Diabetes by OX40 Ligand1

  2003cited by this paper
• Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering

  2003cited by this paper
• Costimulation via OX40L Expressed by B Cells Is Sufficient to Determine the Extent of Primary CD4 Cell Expansion and Th2 Cytokine Secretion In Vivo

  2003cited by this paper
• Biological functions of tumor necrosis factor cytokines and their receptors.

  2003cited by this paper
• Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions

  2003cited by this paper
• LIGHT-deficiency impairs CD8+ T cell expansion, but not effector function.

  2003cited by this paper
• 4-1BB-ligand is regulated on human dendritic cells and induces the production of IL-12.

  2003cited by this paper
• 4-1BB (CD137) Differentially Regulates Murine In Vivo Protein- and Polysaccharide-Specific Immunoglobulin Isotype Responses to Streptococcus pneumoniae

  2003cited by this paper
• Signalling pathways of the TNF superfamily: a double-edged sword

  2003cited by this paper
• OX40 Ligation on Activated T Cells Enhances the Control of Cryptococcus neoformans and Reduces Pulmonary Eosinophilia

  2003cited by this paper
• CD8 T cell responses to infectious pathogens.

  2003cited by this paper
• OX40 (CD134) and OX40 ligand interaction plays an adjuvant role during in vivo Th2 responses

  2003cited by this paper
• T Cell Accumulation in B Cell Follicles Is Regulated by Dendritic Cells and Is Independent of B Cell Activation

  2003cited by this paper
• Therapeutic effect of anti-OX40L and anti-TNF-α MAbs in a murine model of chronic colitis

  2003cited by this paper
• CD137 is expressed by follicular dendritic cells and costimulates B lymphocyte activation in germinal centers

  2002cited by this paper
• Role of GITR in activation response of T lymphocytes.

  2002cited by this paper
• All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction.

  2002cited by this paper
• Constitutive OX40/OX40 Ligand Interaction Induces Autoimmune-Like Diseases1

  2002cited by this paper
• Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB

  2002cited by this paper
• Mouse T cells receive costimulatory signals from LIGHT, a TNF family member.

  2002cited by this paper
• Role of 4-1BB (CD137) in the functional activation of cord blood CD28(-)CD8(+) T cells.

  2002cited by this paper
• In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses

  2002cited by this paper

• HIV Membrane-Proximal External Region Scaffolded Immunogen as Killed Whole-Cell Genome-Reduced Vaccines.

  2026cites this paper
• HVEM costimulatory domain boosts CAR T cell efficacy against solid tumors via enhanced TRAF-mediated TNF signaling

  2026cites this paper
• OX40 signaling in cancer immunotherapy: mechanisms of action, translational applications, and therapeutic perspectives.

  2026cites this paper
• De novo design of small molecule-regulated protein oligomers.

  2026cites this paper
• A motif-vocabulary model of CAR T-cell intracellular domains identifies determinants of immunophenotype differentiation

  2026cites this paper
• Discordant CAR-T cell signaling: implications of divergence from physiological T cell activation

  2025cites this paper
• CD8+ T cell antitumor immunity via human iNKT-DC conjugates.

  2025cites this paper
• Clinical and functional characterization of a novel TNFRSF9 variant causing immune dysregulation with predisposition to EBV-driven lymphomagenesis

  2025cites this paper
• NF-κB: master regulator of cellular responses in health and disease

  2025cites this paper
• Single‐cell landscape of the tumour immune microenvironment in human gynaecologic malignancies

  2025cites this paper
• Bidirectional Communication Between the Innate and Adaptive Immune Systems

  2025cites this paper
• Single-cell analysis reveals an important role of CD137L+ macrophages in the host response to uropathogenic Escherichia coli infection in the bladder

  2025cites this paper
• Monitoring of (Leukemia-Specific) Immune Cells in Stages, Treatment Groups and in the Course of Disease and Therapy Contributes to Qualify Antileukemic Potential and Survival in Patients with AML

  2025cites this paper
• Costimulatory connections: CARMIL2 and CD28.

  2025cites this paper
• Recognition of different subsets of alloreactive T cells by activation-induced markers.

  2025cites this paper
• A systems biology investigation to identify potential biomarkers in leprosy-affected host cells

  2025cites this paper
• Dendritic cell-based vaccines, a promising prospect for ending AIDS and eradication of HIV worldwide: A narrative review on the latest updates.

  2025cites this paper
• Distinct immunological features of oropharyngeal cancer peritumoral tonsillar tissues from inflammatory tonsils and regional lymph nodes: A pilot study

  2025cites this paper
• TNF/TNFR Superfamily Members in Costimulation of T Cell Responses-Revisited.

  2025cites this paper
• TNF superfamily molecules in atherosclerosis: mechanistic insights and therapeutic translation

  2025cites this paper
• The emergence of a new paradigm with signal 1 and signal 2 T-cell engagers in hematology.

  2025cites this paper
• Enhancement of CAR-T cell efficacy and persistence via CD30 costimulation and NF-κB signaling

  2025cites this paper
• Tumour necrosis factor‐alpha at the intersection of renal epithelial and immune cell function

  2025cites this paper
• Next-Generation Immune Checkpoint Inhibitors in Cancer: Mechanisms, Current Clinical Advances, and Future Directions

  2025cites this paper
• Th9 cells provide protective TB immunity

  2025cites this paper
• Intratumoral delivery of 4-1BBL boosts IL-12-triggered anti-glioma immunity

  2025cites this paper
• Influence of Fusobacterium nucleatum on Tumor Necrosis Factor Alpha Therapy in Ulcerative Colitis

  2025cites this paper
• NicheNet-Based Dissection of CD14+ Monocyte Crosstalk with Memory CD4+ T Cells in Human PBMCs

  2025cites this paper
• Casitas b cell lymphoma‑B (Cbl-b): A new therapeutic avenue for small-molecule immunotherapy.

  2024cites this paper
• REXO2 up-regulation is positively correlated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma.

  2024cites this paper
• Intraepithelial Lymphocytes Promote Intestinal Regeneration through CD160/HVEM Signaling.

  2024cites this paper
• Assessing the functional potential of conditioned media derived from amniotic epithelial stem cells engineered on 3D biomimetic scaffolds: An in vitro model for tendon regeneration

  2024cites this paper
• Tregs from human blood differentiate into nonlymphoid tissue–resident effector cells upon TNFR2 costimulation

  2024cites this paper
• Targeting SIGLEC15 as an emerging immunotherapy for anaplastic thyroid cancer.

  2024cites this paper
• TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction

  2024cites this paper
• Immunomodulation by galectin-9: Distinct role in T cell populations, current therapeutic avenues and future potential.

  2024cites this paper
• The new era of immunological treatment, last updated and future consideration of CAR T cell-based drugs.

  2024cites this paper
• Artificial antigen-presenting cells: the booster for the obtaining of functional adoptive cells

  2024cites this paper
• IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy

  2024cites this paper
• Proteomic and cytokine profiling of a CTRP8-RXFP1 glioma mouse model.

  2024cites this paper
• Aging-related biomarker discovery in the era of immune checkpoint inhibitors for cancer patients

  2024cites this paper
• Molecular mechanism of co-stimulatory domains in promoting CAR-T cell anti-tumor efficacy.

  2024cites this paper
• GITR exacerbates lysophosphatidylcholine-induced macrophage pyroptosis in sepsis via posttranslational regulation of NLRP3

  2024cites this paper
• Engineering immune-evasive allogeneic cellular immunotherapies

  2024cites this paper
• Unlocking the potential of iPSC-derived immune cells: engineering iNK and iT cells for cutting-edge immunotherapy

  2024cites this paper
• Chemical-Specific T Cell Tests Aim to Bridge a Gap in Skin Sensitization Evaluation

  2024cites this paper
• Necroptosis-based glioblastoma prognostic subtypes: implications for TME remodeling and therapy response

  2024cites this paper
• Mechanism-Driven Design of Multispecific Antibodies for Targeted Disease Treatment.

  2024cites this paper
• CD8+ T cell priming that is required for curative intratumorally anchored anti-4-1BB immunotherapy is constrained by Tregs

  2024cites this paper
• Immune checkpoint therapy-current perspectives and future directions.

  2023cites this paper
• Immune Checkpoint Inhibitor Associated Myocarditis and Cardiomyopathy: A Translational Review

  2023cites this paper
• SOHO State of the Art Updates and Next Questions | New Pathways and New Targets in PTCL: Staying on Target.

  2023cites this paper
• The expression and prognostic value of co-stimulatory molecules in clear cell renal cell carcinoma (ccRCC).

  2023cites this paper
• DNA methylation of GITR, OX40, 4-1BB, CD27, and CD40 correlates with BAP1 aberrancy and prognosis in uveal melanoma

  2023cites this paper
• Tregs constrain CD8+ T cell priming required for curative intratumorally anchored anti-4-1BB immunotherapy

  2023cites this paper
• NFκB signaling in T cell memory

  2023cites this paper
• TRAF3: Guardian of T lymphocyte functions

  2023cites this paper
• Analysis of Single‐Cell Transcriptome and Surface Protein Expression in Ankylosing Spondylitis Identifies OX40‐Positive and Glucocorticoid‐Induced Tumor Necrosis Factor Receptor–Positive Pathogenic Th17 Cells

  2023cites this paper
• Autoinhibitory structure of preligand association state implicates a new strategy to attain effective DR5 receptor activation

  2023cites this paper
• CD27 agonism coordinates with CD28 and 4-1BB signal to augment the efficacy of CAR-T cells in colorectal tumor

  2023cites this paper
• Dendritic Cell-Based Immunity: Screening of Dendritic Cell Subsets in Breast Cancer-Bearing Mice

  2023cites this paper
• T cells in health and disease

  2023cites this paper
• Vitamin D3 and deconvoluting a rash

  2023cites this paper
• [A shot of synTac to activate CD8+ T cells cytotoxic specific response against HIV].

  2023cites this paper
• CD137L Inhibition Ameliorates Hippocampal Neuroinflammation and Behavioral Deficits in a Mouse Model of Sepsis-Associated Encephalopathy

  2023cites this paper
• T Cell Response in Tuberculosis-Infected Patients Vaccinated against COVID-19

  2023cites this paper
• Fasting mimicking diet in mice delays cancer growth and reduces immunotherapy-associated cardiovascular and systemic side effects

  2023cites this paper
• Advances in vaccine development for cancer prevention and treatment in Lynch Syndrome.

  2023cites this paper
• Strategies for overcoming bottlenecks in allogeneic CAR-T cell therapy

  2023cites this paper
• An optimized flow cytometry protocol for simultaneous detection of T cell activation induced markers and intracellular cytokines: Application to SARS-CoV-2 immune individuals

  2023cites this paper
• Mechanisms of immune modulation in the tumor microenvironment and implications for targeted therapy

  2023cites this paper
• An optimized flow cytometry protocol for simultaneous detection of T cell activation induced markers and intracellular cytokines: Application to SARS-CoV-2 immune individuals

  2023cites this paper
• Development of Adaptive Immunity and Its Role in Lung Remodeling.

  2023cites this paper
• Integrated molecular and immunological features of human T-lymphotropic virus type 1 infection and disease progression to adult T-cell leukaemia or lymphoma.

  2023cites this paper
• BAT6026, a novel anti-OX40 antibody with enhanced antibody dependent cellular cytotoxicity effect for cancer immunotherapy

  2023cites this paper
• An optimized flow cytometry protocol for simultaneous detection of T cell activation induced markers and intracellular cytokines: Application to SARS-CoV-2 immune individuals

  2023cites this paper
• Targeting GITR in cancer immunotherapy – there is no perfect knowledge

  2023cites this paper
• Fundamental Characterization of Antibody Fusion-Single-Chain TNF Recombinant Proteins Directed against Costimulatory TNF Receptors Expressed by T-Lymphocytes

  2023cites this paper
• Cord blood-derived CD19-specific chimeric antigen receptor T cells: an off-the-shelf promising therapeutic option for treatment of diffuse large B-cell lymphoma

  2023cites this paper
• Challenges and opportunities in the development of combination immunotherapy with OX40 agonists

  2023cites this paper
• Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency

  2022cites this paper
• Unlocking the potential of agonist antibodies for treating cancer using antibody engineering.

  2022cites this paper
• Dynamics of T cell repertoire renewal following autologous hematopoietic stem cell transplantation in multiple sclerosis

  2022cites this paper
• When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders.

  2022cites this paper
• Ferroptosis: a double-edged sword mediating immune tolerance of cancer

  2022cites this paper
• Ox40-Cre–mediated deletion of BRD4 reveals an unexpected phenotype of hair follicle stem cells in alopecia

  2022cites this paper
• The different facets of heme-oxygenase 1 in innate and adaptive immunity

  2022cites this paper
• Co-stimulatory molecule clusters correlate with survival, immune infiltration, and tumor mutation burden in non-small cell lung cancer

  2022cites this paper
• Antibody-Targeted TNFRSF Activation for Cancer Immunotherapy: The Role of FcγRIIB Cross-Linking

  2022cites this paper
• Optimization of whole-cell vaccines with CpG/αOX40/cGAMP to strengthen the anti-tumor response of CD4+ T cells in melanomas

  2022cites this paper
• Co-Stimulatory Receptor Signaling in CAR-T Cells

  2022cites this paper
• Adoptive tumor infiltrating lymphocyte transfer as personalized immunotherapy.

  2022cites this paper
• Recent Advances in Solid Tumor CAR-T Cell Therapy: Driving Tumor Cells From Hero to Zero?

  2022cites this paper
• Characterization of Peripheral Blood TCR in Patients with Type 1 Diabetes Mellitus by BD RhapsodyTM VDJ CDR3 Assay

  2022cites this paper
• New insights into checkpoint inhibitor immunotherapy and its combined therapies in hepatocellular carcinoma: from mechanisms to clinical trials

  2022cites this paper
• Dynamic Immune Landscape and VZV-Specific T Cell Responses in Patients With Herpes Zoster and Postherpetic Neuralgia

  2022cites this paper
• Cellular vesicles expressing PD-1-blocking scFv reinvigorate T cell immunity against cancer

  2022cites this paper
• Comprehensive Molecular Analyses of a TNF Family-Based Gene Signature as a Potentially Novel Prognostic Biomarker for Cervical Cancer

  2022cites this paper
• First report on genome wide association study in western Indian population reveals host genetic factors for COVID-19 severity and outcome

  2022cites this paper
• Ovarian Cancer Immunotherapy en Route: IL9 Inhibits Growth of Ovarian Cancer and Upregulates its Expression of Ox40L and 4-1BBL

  2022cites this paper